Our commitment to patients
How we work with patients & advocates
We collaborate with patients, caregivers, and advocacy organizations to build long-term partnerships grounded in trust. Through advisory boards, scientific conferences, community roundtables, and one-on-one conversations, we gather direct input on what patients need and how we can take action. We bring these insights into our research, clinical trials, and resources to better reflect the realities people face — not just in the lab, but in everyday life.
Our scientific approach
We are dedicated to translating science into survival by harnessing the potential of the human immune system to improve the health of people with cancer and infectious diseases.
We are committed to transforming how cancer is treated. With more than 15 years of immunology and technological expertise, our ambition is to develop medicines that work together to treat cancer from multiple angles – training the immune system to recognize cancer more effectively, addressing multiple disease drivers, and targeting tumor cells with precision.
Our investigational therapies include mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies such as antibody-drug conjugates. These are designed to address the full spectrum of cancer, from early-stage disease with high risk of recurrence to advanced and metastatic cancers.
